784
Participants
Start Date
March 2, 2016
Primary Completion Date
November 23, 2016
Study Completion Date
November 16, 2017
Botulinum Toxin A
Injection, 20 Units divided in five 0.1 mL i.m. injections into the glabellar area.
Placebo
Injection, 0.9% sodium chloride divided in five 0.1 mL i.m. injections into glabellar area
Botulinum Toxin A
Injection, 20 Units divided in five 0.1 mL i.m. injections into the glabellar area in up to 3 treatment cycles
RZANY & HUND, Privatpraxis, Berlin
Society Hill Dermatology, Philadelphia
Aesthetic Solutions, Chapel Hill
Total Skin And Beauty Dermatology Center, Pc, Birmingham
Tennessee Clinical Research Center, Nashville
DeNova Research, Chicago
Rosenpark Research, Darmstadt
Skin Specialists, Omaha
About Skin, Greenwood Village
Praxisklinik Fur Dermatologie, Hautzentrum am Starnberger See, Starnberg
Clinical Testing of Beverly Hills, Encino
Maas Clinic, San Francisco
S-thetic Clinic Hamburg, Hamburg
Praxis Klinik Dr. Med. Anita Ruetter, Münster
Carpe Diem, Centre for Aesthetic Medicine, Warsaw
Clinical Research Group Sp. z o.o., Warsaw
Estederm Dr Marcin Ambroziak, Warsaw
High-Med. Przychodnia Specjalistyczna, Warsaw
Lead Sponsor
Croma-Pharma GmbH
INDUSTRY